Form 4: Integra Lifesciences Holdings Executive Reports Stock Transa
Insider Transaction (Form 4)
Chantal Veillon-Berteloot, EVP & CHRO of Integra Lifesciences Holdings Corp, reported a transaction in 1,455 shares of common stock on September 1, 2026.
Summary
- Tax/exercise-price withholding: disposed of 1,455 Common Stock at $16.62 ($24,182) on September 1, 2026; holds 20,772 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Chantal Veillon-Berteloot — Officer (EVP & CHRO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-01 | Tax/exercise-price withholding | Common Stock | 1,455 | $17 | $24.2K | 20,772 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-01 | Tax/exercise-price withholding (1,455 shares) |
Keywords
insider transaction, Form 4, IART, INTEGRA LIFESCIENCES HOLDINGS CORP, neutral, Chantal Veillon-Berteloot
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.